AU Patent

AU2005233612A1 — Proline CCI-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline CCI-779 and CCI-779 using microbial lipase

Assigned to Wyeth LLC · Expires 2005-10-27 · 21y expired

What this patent protects

Patent listed against Torisel.

Drugs covered by this patent

Patent Metadata

Patent number
AU2005233612A1
Jurisdiction
AU
Classification
—
Expires
2005-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.